title: Heterogeneous human NK cell responses to Plasmodium falciparum-infected erythrocytes.
abstract: Human NK cells can respond rapidly to Plasmodium falciparum-infected RBC (iRBC) to produce IFN-gamma. In this study, we have examined the heterogeneity of this response among malaria-naive blood donors. Cells from all donors become partially activated (up-regulating CD69, perforin, and granzyme) upon exposure to iRBC but cells from only a subset of donors become fully activated (additionally up-regulating CD25, IFN-gamma, and surface expression of lysosomal-associated membrane protein 1 (LAMP-1)). Although both CD56dim and CD56bright NK cell populations can express IFN-gamma in response to iRBC, CD25 and LAMP-1 are up-regulated only by CD56dim NK cells and CD69 is up-regulated to a greater extent in this subset; by contrast, perforin and granzyme A are preferentially up-regulated by CD56bright NK cells. NK cells expressing IFN-gamma in response to iRBC always coexpress CD69 and CD25 but rarely LAMP-1, suggesting that individual NK cells respond to iRBC either by IFN-gamma production or cytotoxicity. Furthermore, physical contact with iRBC can, in a proportion of donors, lead to NK cell cytoskeletal reorganization suggestive of functional interactions between the cells. These observations imply that individuals may vary in their ability to mount an innate immune response to malaria infection with obvious implications for disease resistance or susceptibility.
authors.affiliation: Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
authors.forename: Daniel S
authors.initials: DS
authors.lastname: Korbel
authors.forename: Kirsty C
authors.initials: KC
authors.lastname: Newman
authors.forename: Catarina R
authors.initials: CR
authors.lastname: Almeida
authors.forename: Daniel M
authors.initials: DM
authors.lastname: Davis
authors.forename: Eleanor M
authors.initials: EM
authors.lastname: Riley
mesh_terms: D000818:Animals; D015703:Antigens, CD / Q000096:biosynthesis / Q000276:immunology; D000945:Antigens, Differentiation, T-Lymphocyte / Q000096:biosynthesis / Q000276:immunology; D001782:Blood Donors; D018956:CD5 Antigens / Q000096:biosynthesis / Q000276:immunology; D002450:Cell Communication / Q000276:immunology; D002478:Cells, Cultured; D004912:Erythrocytes / Q000382:microbiology*; D005434:Flow Cytometry; D006801:Humans; D007371:Interferon-gamma / Q000096:biosynthesis / Q000276:immunology; D007694:Killer Cells, Natural / Q000276:immunology* / Q000382:microbiology; D037181:Lectins, C-Type; D008213:Lymphocyte Activation / Q000276:immunology*; D052118:Lysosomal-Associated Membrane Protein 1 / Q000096:biosynthesis / Q000276:immunology; D008562:Membrane Glycoproteins / Q000096:biosynthesis / Q000276:immunology; D018613:Microscopy, Confocal; D054353:Perforin; D010963:Plasmodium falciparum / Q000276:immunology*; D052899:Pore Forming Cytotoxic Proteins; D015375:Receptors, Interleukin-2 / Q000096:biosynthesis / Q000276:immunology; D015854:Up-Regulation; D000099192:CD69 Antigens
chemical_list: D015703:Antigens, CD; D000945:Antigens, Differentiation, T-Lymphocyte; D018956:CD5 Antigens; D007371:Interferon-gamma; D037181:Lectins, C-Type; D052118:Lysosomal-Associated Membrane Protein 1; D008562:Membrane Glycoproteins; D054353:Perforin; D052899:Pore Forming Cytotoxic Proteins; D015375:Receptors, Interleukin-2; D000099192:CD69 Antigens